Syntekabio, Inc., An NGS and AI driven drug discovery and development company.
Location: South Korea, Daejeon
Employees: 11-50
Founded date: 2009
Investors 4
| Date | Name | Website |
| - | Timewise I... | cjvc.com |
| 18.05.2023 | Synergy IB... | synergyib.... |
| - | TimewiseIn... | timewisein... |
| - | The Yozma ... | korea.yozm... |
Mentions in press and media 4
| Date | Title | Description |
| 20.10.2025 | Syntekabio Begins Full-Scale Operation of AI-Driven Asset Program | Syntekabio AI Bio Supercomputing (ABS) Data Center in Dungok, Daejeon Syntekabio Launched AI Asset Programs to Identify Antibody and Small-molecule Drug Candidates NEW YORK, NY, UNITED STATES, October 20, 2025 /EINPresswire.com/ -- AI drug ... |
| 14.10.2025 | Syntekabio Advances Ongoing Collaboration with Global Cancer Research Center | Collaboration leverages Syntekabio’s LM-VS™ and DeepMatcher® platforms for large-scale in-silico screening; results shared for independent evaluation DAEJEON, REP. OF KOREA AND NEW YORK, NY, UNITED STATES, October 14, 2025 /EINPresswire.com... |
| 02.09.2024 | Syntekabio collaborates with global compound supplier Enamine for AI-based synthetic drug development | KYIV, UKRAINE, September 2, 2024 /EINPresswire.com/ -- Syntekabio collaborates with global compound supplier Enamine on AI-driven synthetic drug development and global market expansion through a strategic partnership. Syntekabio (CEO Jongsu... |
| 12.08.2022 | AI-Based Drug Discovery and Development Company Syntekabio Begins US Operations | Syntekabio offers AI drug discovery and development platforms as a cloud service in the US and global pharmaceutical markets. Syntekabio offers innovative AI drug discovery solutions for the global biopharma industry, including DeepMatcher®... |